Clinical Trial Update: Multi Immunotherapy to Test Tolerance and Xolair [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating multi-immunotherapy to test tolerance in individuals with food allergy; study completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Food Allergy

Drugs mentioned

• Xolair (omalizumab)

Snippet

Sponsor: Kari Christine Nadeau | Conditions: Food Allergy | Phase 2 | Status: COMPLETED | Results posted: 2017-12-18